Kawasaki disease classification: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(13 intermediate revisions by 3 users not shown)
Line 2: Line 2:
{{Kawasaki disease}}
{{Kawasaki disease}}


{{CMG}}; {{AE}}  
{{CMG}}; {{AE}} {{SH}}
==Overview==
[[Patient|Patients]] whose illness does not meet the [[diagnostic criteria]] of Kawasaki disease, but who have [[fever]] and [[Coronary artery anomalies|coronary artery abnormalities]], are [[Classification|classified]] as atypical or incomplete Kawasaki disease. For patients of atypical or incomplete Kawasaki disease, an evidence of [[Coronary artery anomalies|coronary abnormalities or CAAs]] must be shown on the [[Echocardiography|echocardiogram]].
 
==Classification==
==Classification==
*Patients whose illness does not meet the diagnostic criteria of Kawasaki disease case definition, but who have fever and coronary artery abnormalities are classified as:
*[[Patient|Patients]] whose illness does not meet the [[diagnostic criteria]] of Kawasaki disease, but who have [[fever]] and [[Coronary artery anomalies|coronary artery abnormalities]], are [[Classification|classified]] as:<ref name="pmid24485156">{{cite journal |vauthors=Sánchez-Manubens J, Bou R, Anton J |title=Diagnosis and classification of Kawasaki disease |journal=J. Autoimmun. |volume=48-49 |issue= |pages=113–7 |date=2014 |pmid=24485156 |doi=10.1016/j.jaut.2014.01.010 |url=}}</ref>
**Atypical or incomplete Kawasaki disease
**Atypical Kawasaki disease
**Incomplete Kawasaki disease
*For the patients of atypical or incomplete Kawasaki disease, an evidence of [[Coronary artery anomalies|coronary abnormalities or CAA’s]] must be shown on the [[Echocardiography|echocardiogram]].<ref name="NewburgerTakahashi2004">{{cite journal|last1=Newburger|first1=J. W.|last2=Takahashi|first2=M.|last3=Gerber|first3=M. A.|last4=Gewitz|first4=M. H.|last5=Tani|first5=L. Y.|last6=Burns|first6=J. C.|last7=Shulman|first7=S. T.|last8=Bolger|first8=A. F.|last9=Ferrieri|first9=P.|last10=Baltimore|first10=R. S.|last11=Wilson|first11=W. R.|last12=Baddour|first12=L. M.|last13=Levison|first13=M. E.|last14=Pallasch|first14=T. J.|last15=Falace|first15=D. A.|last16=Taubert|first16=K. A.|title=Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association|journal=PEDIATRICS|volume=114|issue=6|year=2004|pages=1708–1733|issn=0031-4005|doi=10.1542/peds.2004-2182}}</ref>
==References==
{{Reflist|2}}
{{WH}}
{{WS}}
[[Category:Pediatrics]]
[[Category:Cardiovascular diseases]]
[[Category:Angiology]]
[[Category:Cardiology]]
[[Category:Rheumatology]]
[[Category:Dermatology]]
[[Category:Emergency medicine]]
[[Category:Up-To-Date]]

Latest revision as of 19:16, 12 February 2020

Kawasaki disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Kawasaki disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Guidelines for Management

Case Studies

Case #1

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Kawasaki disease classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Kawasaki disease classification

CDC on Kawasaki disease classification

Kawasaki disease classification in the news

Blogs on Kawasaki disease classification

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Kawasaki disease classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dildar Hussain, MBBS [2]

Overview

Patients whose illness does not meet the diagnostic criteria of Kawasaki disease, but who have fever and coronary artery abnormalities, are classified as atypical or incomplete Kawasaki disease. For patients of atypical or incomplete Kawasaki disease, an evidence of coronary abnormalities or CAAs must be shown on the echocardiogram.

Classification

References

  1. Sánchez-Manubens J, Bou R, Anton J (2014). "Diagnosis and classification of Kawasaki disease". J. Autoimmun. 48-49: 113–7. doi:10.1016/j.jaut.2014.01.010. PMID 24485156.
  2. Newburger, J. W.; Takahashi, M.; Gerber, M. A.; Gewitz, M. H.; Tani, L. Y.; Burns, J. C.; Shulman, S. T.; Bolger, A. F.; Ferrieri, P.; Baltimore, R. S.; Wilson, W. R.; Baddour, L. M.; Levison, M. E.; Pallasch, T. J.; Falace, D. A.; Taubert, K. A. (2004). "Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association". PEDIATRICS. 114 (6): 1708–1733. doi:10.1542/peds.2004-2182. ISSN 0031-4005.

Template:WH Template:WS